2024-01-012024-12-312024-12-31false08683288DREAM MEDICAL LIMITED2025-09-22falseiso4217:GBPxbrli:pure086832882023-12-31086832882024-12-31086832882024-01-012024-12-31086832882022-12-31086832882023-12-31086832882023-01-012023-12-3108683288bus:SmallEntities2024-01-012024-12-3108683288bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3108683288bus:FullAccounts2024-01-012024-12-3108683288bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108683288core:WithinOneYear2024-12-3108683288core:AfterOneYear2024-12-3108683288core:WithinOneYear2023-12-3108683288core:AfterOneYear2023-12-3108683288core:ShareCapital2024-12-3108683288core:SharePremium2024-12-3108683288core:RevaluationReserve2024-12-3108683288core:OtherReservesSubtotal2024-12-3108683288core:RetainedEarningsAccumulatedLosses2024-12-3108683288core:ShareCapital2023-12-3108683288core:SharePremium2023-12-3108683288core:RevaluationReserve2023-12-3108683288core:OtherReservesSubtotal2023-12-3108683288core:RetainedEarningsAccumulatedLosses2023-12-3108683288core:LandBuildings2024-12-3108683288core:PlantMachinery2024-12-3108683288core:Vehicles2024-12-3108683288core:FurnitureFittings2024-12-3108683288core:OfficeEquipment2024-12-3108683288core:NetGoodwill2024-12-3108683288core:IntangibleAssetsOtherThanGoodwill2024-12-3108683288core:ListedExchangeTraded2024-12-3108683288core:UnlistedNon-exchangeTraded2024-12-3108683288core:LandBuildings2023-12-3108683288core:PlantMachinery2023-12-3108683288core:Vehicles2023-12-3108683288core:FurnitureFittings2023-12-3108683288core:OfficeEquipment2023-12-3108683288core:NetGoodwill2023-12-3108683288core:IntangibleAssetsOtherThanGoodwill2023-12-3108683288core:ListedExchangeTraded2023-12-3108683288core:UnlistedNon-exchangeTraded2023-12-3108683288core:LandBuildings2024-01-012024-12-3108683288core:PlantMachinery2024-01-012024-12-3108683288core:Vehicles2024-01-012024-12-3108683288core:FurnitureFittings2024-01-012024-12-3108683288core:OfficeEquipment2024-01-012024-12-3108683288core:NetGoodwill2024-01-012024-12-3108683288core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108683288core:ListedExchangeTraded2024-01-012024-12-3108683288core:UnlistedNon-exchangeTraded2024-01-012024-12-3108683288core:MoreThanFiveYears2024-01-012024-12-3108683288core:Non-currentFinancialInstruments2024-12-3108683288core:Non-currentFinancialInstruments2023-12-3108683288dpl:CostSales2024-01-012024-12-3108683288dpl:DistributionCosts2024-01-012024-12-3108683288core:LandBuildings2024-01-012024-12-3108683288core:PlantMachinery2024-01-012024-12-3108683288core:Vehicles2024-01-012024-12-3108683288core:FurnitureFittings2024-01-012024-12-3108683288core:OfficeEquipment2024-01-012024-12-3108683288dpl:AdministrativeExpenses2024-01-012024-12-3108683288core:NetGoodwill2024-01-012024-12-3108683288core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108683288dpl:GroupUndertakings2024-01-012024-12-3108683288dpl:ParticipatingInterests2024-01-012024-12-3108683288dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3108683288core:ListedExchangeTraded2024-01-012024-12-3108683288dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3108683288core:UnlistedNon-exchangeTraded2024-01-012024-12-3108683288dpl:CostSales2023-01-012023-12-3108683288dpl:DistributionCosts2023-01-012023-12-3108683288core:LandBuildings2023-01-012023-12-3108683288core:PlantMachinery2023-01-012023-12-3108683288core:Vehicles2023-01-012023-12-3108683288core:FurnitureFittings2023-01-012023-12-3108683288core:OfficeEquipment2023-01-012023-12-3108683288dpl:AdministrativeExpenses2023-01-012023-12-3108683288core:NetGoodwill2023-01-012023-12-3108683288core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3108683288dpl:GroupUndertakings2023-01-012023-12-3108683288dpl:ParticipatingInterests2023-01-012023-12-3108683288dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3108683288core:ListedExchangeTraded2023-01-012023-12-3108683288dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3108683288core:UnlistedNon-exchangeTraded2023-01-012023-12-3108683288core:NetGoodwill2024-12-3108683288core:IntangibleAssetsOtherThanGoodwill2024-12-3108683288core:LandBuildings2024-12-3108683288core:PlantMachinery2024-12-3108683288core:Vehicles2024-12-3108683288core:FurnitureFittings2024-12-3108683288core:OfficeEquipment2024-12-3108683288core:AfterOneYear2024-12-3108683288core:WithinOneYear2024-12-3108683288core:ListedExchangeTraded2024-12-3108683288core:UnlistedNon-exchangeTraded2024-12-3108683288core:ShareCapital2024-12-3108683288core:SharePremium2024-12-3108683288core:RevaluationReserve2024-12-3108683288core:OtherReservesSubtotal2024-12-3108683288core:RetainedEarningsAccumulatedLosses2024-12-3108683288core:NetGoodwill2023-12-3108683288core:IntangibleAssetsOtherThanGoodwill2023-12-3108683288core:LandBuildings2023-12-3108683288core:PlantMachinery2023-12-3108683288core:Vehicles2023-12-3108683288core:FurnitureFittings2023-12-3108683288core:OfficeEquipment2023-12-3108683288core:AfterOneYear2023-12-3108683288core:WithinOneYear2023-12-3108683288core:ListedExchangeTraded2023-12-3108683288core:UnlistedNon-exchangeTraded2023-12-3108683288core:ShareCapital2023-12-3108683288core:SharePremium2023-12-3108683288core:RevaluationReserve2023-12-3108683288core:OtherReservesSubtotal2023-12-3108683288core:RetainedEarningsAccumulatedLosses2023-12-3108683288core:NetGoodwill2022-12-3108683288core:IntangibleAssetsOtherThanGoodwill2022-12-3108683288core:LandBuildings2022-12-3108683288core:PlantMachinery2022-12-3108683288core:Vehicles2022-12-3108683288core:FurnitureFittings2022-12-3108683288core:OfficeEquipment2022-12-3108683288core:AfterOneYear2022-12-3108683288core:WithinOneYear2022-12-3108683288core:ListedExchangeTraded2022-12-3108683288core:UnlistedNon-exchangeTraded2022-12-3108683288core:ShareCapital2022-12-3108683288core:SharePremium2022-12-3108683288core:RevaluationReserve2022-12-3108683288core:OtherReservesSubtotal2022-12-3108683288core:RetainedEarningsAccumulatedLosses2022-12-3108683288core:AfterOneYear2024-01-012024-12-3108683288core:WithinOneYear2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108683288core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3108683288core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3108683288core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3108683288core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3108683288core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3108683288bus:Director12024-01-012024-12-31

DREAM MEDICAL LIMITED

Registered Number
08683288
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

DREAM MEDICAL LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

Sonia Mary Browne

Registered Address

214 Grangewood House 43 Oakwood Hill
Loughton, Essex,
IG10 3TZ

Registered Number

08683288 (England and Wales)
DREAM MEDICAL LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3-282
-282
Current assets
Debtors4545,538371,195
Cash at bank and on hand1,59373,653
547,131444,848
Creditors amounts falling due within one year5(768,478)(454,240)
Net current assets (liabilities)(221,347)(9,392)
Total assets less current liabilities(221,347)(9,110)
Net assets(221,347)(9,110)
Capital and reserves
Called up share capital11
Profit and loss account(221,348)(9,111)
Shareholders' funds(221,347)(9,110)
The financial statements were approved and authorised for issue by the Director on 22 September 2025, and are signed on its behalf by:
Sonia Mary Browne
Director
Registered Company No. 08683288
DREAM MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Current taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

Straight line (years)
Office Equipment3
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20242023
Average number of employees during the year67
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 2429,07629,076
At 31 December 2429,07629,076
Depreciation and impairment
At 01 January 2428,79428,794
Charge for year282282
At 31 December 2429,07629,076
Net book value
At 31 December 24--
At 31 December 23282282
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables113,317338,791
Amounts owed by group undertakings416,939-
Other debtors6,29832,133
Prepayments and accrued income8,984271
Total545,538371,195
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables22,4024,722
Bank borrowings and overdrafts582,470349,619
Taxation and social security28,06580,506
Other creditors135,54119,393
Total768,478454,240